Back
Cellectar Biosciences Stock Price Chart
2025 Gold Forecast: A Perfect Storm for Demand
Discover our Gold Price Outlook for 2025--FREE--here
Sell
43
CLRB
Cellectar Biosciences
Last Price:
$0.31
Seasonality Move:
2.33%
7 Day Trial
ALL ACCESS PASS
$
7
FREE REPORT: 2025 Gold Price Outlook
Get Your Copy of "2025 Gold Forecast: A Perfect Storm for Demand" Here.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CLRB is experiencing slight buying pressure.
Cellectar Biosciences Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.27 | Buy |
| 20-day SMA: | 0.73 | Sell |
| 50-day SMA: | 1.45 | Sell |
| 200-day SMA: | 2.41 | Sell |
| 8-day EMA: | 0.33 | Sell |
| 20-day EMA: | 0.66 | Sell |
| 50-day EMA: | 1.22 | Sell |
| 200-day EMA: | 2.09 | Sell |
Cellectar Biosciences Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.38 | Sell |
| Relative Strength Index (14 RSI): | 15.52 | Sell |
| Chaikin Money Flow: | -145491 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.29 - 1.51) | Sell |
| Bollinger Bands (100): | (1.17 - 2.37) | Sell |
Cellectar Biosciences Technical Analysis
| Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Cellectar Biosciences Stock
Is Cellectar Biosciences Stock a Buy?
-
Cellectar Biosciences share price is 0.31 while CLRB 8-day simple moving average is 0.27, which is a Buy signal.
-
The stock price of CLRB is 0.31 while Cellectar Biosciences 20-day SMA is 0.73, which makes it a Sell.
-
Cellectar Biosciences 50-day simple moving average is 1.45 while CLRB share price is 0.31, making it a Sell technically.
-
CLRB stock price is 0.31 and Cellectar Biosciences 200-day simple moving average is 2.41, creating a Sell signal.
CLRB Technical Analysis vs Fundamental Analysis
Sell
43
Cellectar Biosciences (CLRB)
is a Sell
Is Cellectar Biosciences a Buy or a Sell?
-
Cellectar Biosciences stock is rated a SellThe current Cellectar Biosciences [CLRB] share price is $0.31. The Score for CLRB is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
Cellectar Biosciences Stock Info
Market Cap:
12.7M
Price in USD:
0.31
Share Volume:
2.6M
Cellectar Biosciences 52-Week Range
52-Week High:
4.45
52-Week Low:
0.22
Sell
43
Cellectar Biosciences (CLRB)
is a Sell
Cellectar Biosciences Share Price Forecast
-
What is the Cellectar Biosciences stock price today?The Cellectar Biosciences stock price is 0.31 USD today.
-
Will CLRB stock go up or go down?Cellectar Biosciences> share price is forecast to RISE/FALL based on technical indicators
-
Is Cellectar Biosciences overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Cellectar Biosciences is overvalued.
Is Cellectar Biosciences Stock a Buy?
-
Cellectar Biosciences share price is 0.31 while CLRB 8-day exponential moving average is 0.33, which is a Sell signal.
-
The stock price of CLRB is 0.31 while Cellectar Biosciences 20-day EMA is 0.66, which makes it a Sell.
-
Cellectar Biosciences 50-day exponential moving average is 1.22 while CLRB share price is 0.31, making it a Sell technically.
-
CLRB stock price is 0.31 and Cellectar Biosciences 200-day simple moving average is 2.09, creating a Sell signal.
Fundamental Analysis of Cellectar Biosciences
Is Cellectar Biosciences a good investment?
-
Analysts estimate an earnings increase this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.26 per share, and an increase next year of $0.89 per share.
Technical Analysis of Cellectar Biosciences
Should I short Cellectar Biosciences stock?
-
CLRB Moving Average Covergence Divergence (MACD) indicator is -0.38, suggesting Cellectar Biosciences is a Sell
-
Cellectar Biosciences Relative Strength Index (RSI) is 15.52, which suggest Cellectar Biosciences is oversold
-
The Bollinger Bands (25) for Cellectar Biosciences is (0.29 - 1.51), which suggest Cellectar Biosciences is a Sell
-
The Bollinger Bands (100) for Cellectar Biosciences is (1.17 - 2.37), which suggest Cellectar Biosciences is a Sell
* Cellectar Biosciences stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.